Pharmacogenetics and heart failure: a convergence with carvedilol

Pharmacotherapy. 1997 Jul-Aug;17(4):637-9.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adrenergic beta-Antagonists / metabolism*
  • Adrenergic beta-Antagonists / therapeutic use
  • Carbazoles / metabolism*
  • Carbazoles / therapeutic use
  • Carvedilol
  • Cytochrome P-450 CYP2D6 / genetics
  • Cytochrome P-450 CYP2D6 / metabolism*
  • Heart Failure / drug therapy*
  • Heart Failure / genetics
  • Humans
  • Pharmacogenetics
  • Propanolamines / metabolism*
  • Propanolamines / therapeutic use
  • Vasodilator Agents / metabolism*
  • Vasodilator Agents / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Carbazoles
  • Propanolamines
  • Vasodilator Agents
  • Carvedilol
  • Cytochrome P-450 CYP2D6